Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Retroviral Agents”

1,947 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,947 results

Testing effectiveness (Phase 2)Study completedNCT00001132
What this trial is testing

Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug Combination

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 80
Testing effectiveness (Phase 2)Study completedNCT00002114
What this trial is testing

A Double-Blind, Randomized Parallel Group Study Comparing Procysteine to Placebo in HIV-Infected Patients Who Are Taking Antiretroviral Nucleosides

Who this might be right for
HIV Infections
Free Radical Sciences 125
Not applicableLooking for participantsNCT05789901
What this trial is testing

The MARVIN Chatbots to Provide Information for Different Health Conditions

Who this might be right for
HIV InfectionsBreast CancerPediatric Emergency Medicine
McGill University Health Centre/Research Institute of the McGill University Health Centre 400
Not applicableWithdrawnNCT04468789
What this trial is testing

Evaluation of Six-month HIV Treatment Dispensing in South Africa

Who this might be right for
HIV
Boston University
Post-approval studies (Phase 4)Study completedNCT00108862
What this trial is testing

Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis

Who this might be right for
HIV InfectionTuberculosis
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 809
Testing effectiveness (Phase 2)Study completedNCT03435146
What this trial is testing

Safety Tolerability DDI Short Course Treatment of LTBI Infection With High-dose Rifapentine and Isoniazid or Standard Isoniazid Preventive Therapy in HIV+ Patients (DOLPHIN & DOLPHIN TOO)

Who this might be right for
Respiratory Tract InfectionsHIV Infections
The Aurum Institute NPC 135
Not applicableStudy completedNCT00273780
What this trial is testing

Highly Active Antiretroviral Therapy (HAART) Adherence Interventions

Who this might be right for
HIV Infections
University of Washington 400
Not applicableStudy completedNCT03500172
What this trial is testing

HIV Treatment Retention Interventions for Women Living With HIV (Siyaphambili Study)

Who this might be right for
HIV-1 Virologic Response
Johns Hopkins Bloomberg School of Public Health 1,391
Not applicableStudy completedNCT02380391
What this trial is testing

EValuation of REsidual Platelet REactivity After Acute Coronary Syndrome (ST+/ST-) in HIV

Who this might be right for
Acute Coronary SyndromeHIV
Saint Antoine University Hospital 260
Not applicableEnded earlyNCT00006326
What this trial is testing

Safety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing Nelfinavir

Who this might be right for
HIV Infections
Agouron Pharmaceuticals 60
Not applicableStudy completedNCT01667068
What this trial is testing

Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up

Who this might be right for
Coronary Heart DiseaseHeart FailureHIV+2 more
University Hospital, Essen 1,481
Early research (Phase 1)Active Not RecruitingNCT05612178
What this trial is testing

Evaluate the Safety and Effects of Repeated Doses of 3BNC117-LS and 10-1074-LS on Persistent Viral Reservoirs in People Living With HIV and on Suppressive Antiretroviral Therapy

Who this might be right for
HIV-1
National Institute of Allergy and Infectious Diseases (NIAID) 105
Not applicableStudy completedNCT04418076
What this trial is testing

Project SMART Automated Pillbox Study

Who this might be right for
HIV/AIDSCocaine Use
Yale University 78
Large-scale testing (Phase 3)Study completedNCT01780506
What this trial is testing

Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positive, Antiretroviral Treatment-Naive Adults

Who this might be right for
HIVHIV Infections
Gilead Sciences 872
Not applicableStudy completedNCT00749840
What this trial is testing

Attitudes and Beliefs and the Steps of HIV Care

Who this might be right for
Human Immunodeficiency Virus Infections
M.D. Anderson Cancer Center 200
Not applicableStudy completedNCT00120510
What this trial is testing

Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in Haiti

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 816
Post-approval studies (Phase 4)Study completedNCT00549198
What this trial is testing

KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
GlaxoSmithKline 392
Large-scale testing (Phase 3)Study completedNCT03297216
What this trial is testing

Improving Pregnancy Outcomes With Progesterone

Who this might be right for
Pre-term BirthHIV-1-infection
University of North Carolina, Chapel Hill 800
Large-scale testing (Phase 3)Study completedNCT01263015
What this trial is testing

A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial)

Who this might be right for
Infection, Human Immunodeficiency Virus I
ViiV Healthcare 844
Testing effectiveness (Phase 2)Study completedNCT00002390
What this trial is testing

The Safety and Effectiveness of Different Doses of 1592U89 in HIV-Infected Patients

Who this might be right for
HIV Infections
Glaxo Wellcome
Load More Results